Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Phreesia, Inc. (PHR : NYSE)

• Company Description    Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. Number of Employees: 2,082

• Price / Volume Information    Yesterday's Closing Price: $24.19 Daily Weekly Monthly 20 Day Moving Average: 1,074,343 shares Shares Outstanding: 59.91 (millions) Market Capitalization: $1,449.32 (millions) Beta: 0.72 52 Week High: $32.76 52 Week Low: $17.07 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -13.64% -15.16% 12 Week -5.73% -14.37% Year To Date -3.86% -9.58%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1521 Concord Pike Suite 301 PMB 221 - Wilmington,DE 19803 USA ph: 888-654-7473 fax: 646-607-1776 investors@phreesia.com http://www.phreesia.com

• General Corporate Information    Officers Chaim Indig - Chief Executive Officer Michael Weintraub - Chairman Balaji Gandhi - Chief Financial Officer Yvonne Hui - Vice President Edward Cahill - Director Peer Information Phreesia, Inc. (HLIS) Phreesia, Inc. (AZTA) Phreesia, Inc. (APYI) Phreesia, Inc. (RNVA) Phreesia, Inc. (HMSY) Phreesia, Inc. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 71944F106 SIC: 7389 Fiscal Year Fiscal Year End: January Last Reported Quarter: 07/01/25 Next Expected EPS Date: 12/08/25 Share - Related Items Shares Outstanding: 59.91 Most Recent Split Date: (:1) Beta: 0.72 Market Capitalization: $1,449.32 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.03 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.10 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 12/08/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 4.86 Price/Cash Flow: - Price / Sales: 3.22 EPS Growth vs. Year Ago Period: 103.23% vs. Previous Quarter: 114.29% Sales Growth vs. Year Ago Period: 14.83% vs. Previous Quarter: 1.14% ROE 07/31/25 - -8.75 04/30/25 - -16.23 01/31/25 - -22.87 ROA 07/31/25 - -6.12 04/30/25 - -11.19 01/31/25 - -15.62 Current Ratio 07/31/25 - 2.12 04/30/25 - 1.95 01/31/25 - 1.78 Quick Ratio 07/31/25 - - 04/30/25 - 1.95 01/31/25 - 1.78 Operating Margin 07/31/25 - -5.35 04/30/25 - -9.83 01/31/25 - -13.94 Net Margin 07/31/25 - -5.35 04/30/25 - -9.83 01/31/25 - -13.94 Pre-Tax Margin 07/31/25 - -5.13 04/30/25 - -9.15 01/31/25 - -13.29 Book Value 07/31/25 - 4.97 04/30/25 - 4.74 01/31/25 - 4.56 Inventory Turnover 07/31/25 - - 04/30/25 - - 01/31/25 - - Debt-to-Equity 07/31/25 - 0.02 04/30/25 - 0.02 01/31/25 - 0.03 Debt-to-Capital 07/31/25 - 1.51 04/30/25 - 2.14 01/31/25 - 2.99

Powered by Zacks Investment Research ©